Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr.
www.bloomberg.com
#Moderna #Wins #Narrower #Approval #Covid #Vaccine
Bloomberg’s Morning Briefing newsletter will resume on Jan. 2. www.bloomberg.com #Warner #Bros #Set #Snub #Paramount #Offer Related reading:Israel Ups Defense…
BHP Group posted earnings at the upper end of analyst expectations, driven by a historic metals rally and a years-long…
Investors are piling in to exchange-traded products, betting that stock-market volatility will increase from rock-bottom levels. But while they wait…
